Osiris Therapeutics focuses on research, development, and manufacturing of regenerative medicine products in orthopedics, sports medicine, and wound care. Their product line includes Grafix, Stravix, BIO4, and Cartiform. They are also actively involved in advancing their research in bioengineered stem cell and tissue-based products. In 2019, Osiris Therapeutics was acquired by Smith & Nephew.